BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 10467217)

  • 1. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
    Hall WD
    Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.
    Kocemba J; Kawecka-Jaszcz K; Gryglewska B; Grodzicki T
    J Hum Hypertens; 1998 Sep; 12(9):621-6. PubMed ID: 9783491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial.
    Staessen JA; Thijs L; Gasowski J; Cells H; Fagard RH
    Am J Cardiol; 1998 Nov; 82(9B):20R-22R. PubMed ID: 9822139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
    Staessen J; Amery A; Birkenhäger W; Bulpitt CJ; Cox J; de Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):120-5. PubMed ID: 1375678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.
    Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R
    Lancet; 1998 Oct; 352(9137):1347-51. PubMed ID: 9802273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
    Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; de Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    J Hum Hypertens; 1999 Feb; 13(2):135-45. PubMed ID: 10100063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Fagard RH; Staessen JA
    Clin Exp Hypertens; 1999; 21(5-6):491-7. PubMed ID: 10423075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials.
    Staessen J; Fagard R; Amery A
    J Hum Hypertens; 1991 Dec; 5(6):469-74. PubMed ID: 1791605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
    Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
    Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
    JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions.
    Black HR
    J Hypertens Suppl; 1999 Dec; 17(5):S49-54. PubMed ID: 10706327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
    S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
    Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; de Leeuw PW; Efstratopoulos AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    Hypertension; 1998 Sep; 32(3):410-6. PubMed ID: 9740604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
    Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials in isolated systolic hypertension: an update.
    Waeber B
    Curr Hypertens Rep; 2003 Aug; 5(4):329-36. PubMed ID: 12844468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of diastolic blood pressure when treating isolated systolic hypertension.
    Somes GW; Pahor M; Shorr RI; Cushman WC; Applegate WB
    Arch Intern Med; 1999 Sep; 159(17):2004-9. PubMed ID: 10510985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated systolic hypertension: a new challenge in medicine.
    Sulbarán TA; Silva ER; Maestre G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S44-7. PubMed ID: 11986893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.